REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial results after market close on Thursday, March 8, 2018. Codexis management will hold an investment community conference call at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss financial results and provide a company update.
| Live Call: |
U.S. |
855 890 8665 |
| |
International |
720 634 2938 |
| |
Passcode |
3990608 |
| |
|
|
| Live Webcast: |
Codexis IR Website |
| |
The webcast will be archived for 30 days. |
| |
|
|
| Replay: |
U.S. |
855 859 2056 |
| |
International |
404 537 3406 |
| |
Passcode |
3990608 |
| |
The replay will be available for 48 hours |
| |
|
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its proprietary CodeEvolver® technology to develop proteins for a variety of high-value industrial applications, including as biocatalysts for the commercial manufacture of pharmaceuticals and fine chemicals, and enzymes as biotherapeutics and for use in molecular diagnostics. Codexis’ proven technology enables significant improvements in protein performance meeting customer needs for rapid, cost-effective and sustainable manufacturing in multiple commercial scale implementations of biocatalytic processes. For more information, see www.codexis.com.
CONTACTS
Investors
LHA Investor Relations
Jody Cain, 310 691 7100
jcain@lhai.com
Source: Codexis, Inc.
